Meiji Yasuda Asset Management Co Ltd. Acquires Shares of 13,626 Cardinal Health, Inc. $CAH

Key Points

• Meiji Yasuda Asset Management acquired 13,626 Cardinal Health shares worth approximately $3.24 million, while institutional investors collectively own 87.17% of the company.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $266.56; recent targets range from $260 to $280.
• Cardinal Health exceeded quarterly EPS expectations, reporting $2.91 versus $2.42 consensus, while revenue rose 5.8% year over year. The company also maintained fiscal 2027 adjusted EPS guidance of $12.40–$12.60 and declared a $0.5158 quarterly dividend.

Meiji Yasuda Asset Management Co Ltd. bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 13,626 shares of the company's stock, valued at approximately $3,237,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Cardinal Health by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company's stock valued at $6,461,179,000 after acquiring an additional 617,775 shares during the period. BlackRock Inc. bought a new position in shares of Cardinal Health in the second quarter worth $6,293,115,000. State Street Corp increased its position in shares of Cardinal Health by 1.8% in the fourth quarter. State Street Corp now owns 12,509,230 shares of the company's stock worth $2,570,647,000 after purchasing an additional 221,497 shares during the period. Geode Capital Management LLC raised its stake in Cardinal Health by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company's stock valued at $1,336,750,000 after purchasing an additional 43,924 shares in the last quarter. Finally, Wellington Management Group LLP raised its stake in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock valued at $911,010,000 after purchasing an additional 3,511,579 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have issued reports on CAH. Royal Bank Of Canada began coverage on shares of Cardinal Health in a research note on Wednesday, August 19th. They set an "outperform" rating and a $276.00 price objective on the stock. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, July 4th. Barclays boosted their price objective on shares of Cardinal Health from $258.00 to $275.00 and gave the company an "overweight" rating in a research report on Thursday, August 13th. Citigroup upped their target price on Cardinal Health from $265.00 to $280.00 and gave the stock a "buy" rating in a research note on Wednesday, August 12th. Finally, JPMorgan Chase & Co. raised their target price on Cardinal Health from $215.00 to $260.00 and gave the company a "neutral" rating in a report on Thursday, August 13th. Sixteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and a consensus target price of $266.56.

Cardinal Health Stock Up 1.1%

Shares of CAH opened at $232.13 on Tuesday. Cardinal Health, Inc. has a 12-month low of $145.87 and a 12-month high of $258.30. The business has a 50-day simple moving average of $232.13 and a two-hundred day simple moving average of $217.96. The stock has a market cap of $53.99 billion, a PE ratio of 32.11, a PEG ratio of 1.23 and a beta of 0.49.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, beating the consensus estimate of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The business's quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the company earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, equities research analysts expect that Cardinal Health, Inc. will post 12.54 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be given a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health's dividend payout ratio (DPR) is currently 28.49%.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, CEO Jason M. Hollar sold 44,529 shares of the company's stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $236.18, for a total value of $10,516,859.22. Following the completion of the transaction, the chief executive officer directly owned 190,603 shares in the company, valued at approximately $45,016,616.54. This represents a 18.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michelle D. Greene sold 11,650 shares of the firm's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the transaction, the insider directly owned 10,330 shares of the company's stock, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 210,271 shares of company stock worth $49,626,657 over the last quarter. Insiders own 0.12% of the company's stock.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source